Detalhe da pesquisa
1.
The Cost of Hope: a candid roundtable discussion.
J Natl Compr Canc Netw
; 11(5 Suppl): 633-5, 2013 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-23704231
2.
Overall Survival and Updated Results for Sunitinib Compared With Interferon Alfa in Patients With Metastatic Renal Cell Carcinoma.
J Clin Oncol
; 41(11): 1965-1971, 2023 04 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-37018919
3.
A phase I dose escalation study of TTI-237 in patients with advanced malignant solid tumors.
Invest New Drugs
; 30(1): 266-72, 2012 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-20697774
4.
A phase II study of tandutinib (MLN518), a selective inhibitor of type III tyrosine receptor kinases, in patients with metastatic renal cell carcinoma.
Invest New Drugs
; 30(1): 364-7, 2012 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-20711630
5.
Phase I/II trial of subcutaneous interleukin-2, granulocyte-macrophage colony-stimulating factor and interferon-α in patients with metastatic renal cell carcinoma.
BJU Int
; 109(1): 63-9, 2012 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-21244601
6.
Clinical and immunomodulatory effects of bevacizumab and low-dose interleukin-2 in patients with metastatic renal cell carcinoma: results from a phase II trial.
BJU Int
; 107(4): 562-70, 2011 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-20840548
7.
Casein kinase I delta/epsilon phosphorylates topoisomerase IIalpha at serine-1106 and modulates DNA cleavage activity.
Nucleic Acids Res
; 37(2): 382-92, 2009 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-19043076
8.
Summary from the Kidney Cancer Association's Inaugural Think Thank: Coalition for a Cure.
Clin Genitourin Cancer
; 19(2): 167-175, 2021 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-33358149
9.
Disease-associated bias in T helper type 1 (Th1)/Th2 CD4(+) T cell responses against MAGE-6 in HLA-DRB10401(+) patients with renal cell carcinoma or melanoma.
J Exp Med
; 196(5): 619-28, 2002 Sep 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-12208877
10.
Sunitinib versus interferon alfa in metastatic renal-cell carcinoma.
N Engl J Med
; 356(2): 115-24, 2007 Jan 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-17215529
11.
Sorafenib in advanced clear-cell renal-cell carcinoma.
N Engl J Med
; 356(2): 125-34, 2007 Jan 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-17215530
12.
Safety and efficacy of sorafenib in elderly patients treated in the North American advanced renal cell carcinoma sorafenib expanded access program.
Oncology
; 78(5-6): 340-7, 2010.
Artigo
em Inglês
| MEDLINE | ID: mdl-20733337
13.
RANK ligand: effects of inhibition.
Curr Oncol Rep
; 12(2): 80-6, 2010 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-20425591
14.
Enhancement in specific CD8+ T cell recognition of EphA2+ tumors in vitro and in vivo after treatment with ligand agonists.
J Immunol
; 181(11): 7721-7, 2008 Dec 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-19017961
15.
A phase I study with neratinib (HKI-272), an irreversible pan ErbB receptor tyrosine kinase inhibitor, in patients with solid tumors.
Clin Cancer Res
; 15(7): 2552-8, 2009 Apr 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-19318484
16.
Myeloid-derived suppressor cells: a novel therapeutic target.
Curr Oncol Rep
; 11(2): 87-93, 2009 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-19216839
17.
Antitumor effects of sunitinib or sorafenib in patients with metastatic renal cell carcinoma who received prior antiangiogenic therapy.
J Urol
; 179(1): 81-6; discussion 86, 2008 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-17997441
18.
von Hippel-Lindau gene status and response to vascular endothelial growth factor targeted therapy for metastatic clear cell renal cell carcinoma.
J Urol
; 180(3): 860-5; discussion 865-6, 2008 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-18635227
19.
Phase I trial of PEG-interferon and recombinant IL-2 in patients with metastatic renal cell carcinoma.
Cancer Chemother Pharmacol
; 62(2): 347-54, 2008 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-17909807
20.
Improving immunotherapy by conditionally enhancing MHC class I presentation of tumor antigen-derived Peptide epitopes.
Crit Rev Immunol
; 27(5): 485-93, 2007.
Artigo
em Inglês
| MEDLINE | ID: mdl-18197809